Grandeur Peak Global Advisors LLC Lowers Position in OrthoPediatrics Corp. $KIDS

Key Points

• Grandeur Peak Global Advisors cut its OrthoPediatrics stake by 47% in the second quarter, selling 44,236 shares and retaining 49,854 shares valued at approximately $954,000. Institutional investors collectively own 69.05% of the company.
• Insiders sold 114,900 shares worth about $2.83 million over the past 90 days, including two 18,000-share sales at $24.28 per share by a major shareholder and a director.
• OrthoPediatrics beat quarterly revenue and EPS expectations, reporting $70.51 million in revenue and an adjusted loss of $0.26 per share. Analysts maintain a “Moderate Buy” consensus with an average price target of $26.44.

Grandeur Peak Global Advisors LLC decreased its holdings in shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 47.0% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 49,854 shares of the company's stock after selling 44,236 shares during the period. Grandeur Peak Global Advisors LLC owned approximately 0.19% of OrthoPediatrics worth $954,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in OrthoPediatrics by 6.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,995 shares of the company's stock worth $246,000 after acquiring an additional 645 shares during the last quarter. Millennium Management LLC boosted its position in shares of OrthoPediatrics by 55.3% during the 1st quarter. Millennium Management LLC now owns 656,578 shares of the company's stock valued at $16,172,000 after acquiring an additional 233,873 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in shares of OrthoPediatrics by 112.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 200,439 shares of the company's stock valued at $4,937,000 after acquiring an additional 106,041 shares during the last quarter. Jane Street Group LLC purchased a new position in shares of OrthoPediatrics during the first quarter worth about $389,000. Finally, American Century Companies Inc. grew its holdings in shares of OrthoPediatrics by 12.5% during the second quarter. American Century Companies Inc. now owns 34,486 shares of the company's stock worth $741,000 after purchasing an additional 3,828 shares in the last quarter. 69.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at OrthoPediatrics

In other news, major shareholder Squadron Capital Llc sold 18,000 shares of the company's stock in a transaction on Wednesday, August 26th. The shares were sold at an average price of $24.28, for a total value of $437,040.00. Following the completion of the sale, the insider owned 6,863,464 shares of the company's stock, valued at approximately $166,644,905.92. This represents a 0.26% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director David R. Pelizzon sold 18,000 shares of the stock in a transaction on Wednesday, August 26th. The shares were sold at an average price of $24.28, for a total transaction of $437,040.00. Following the transaction, the director directly owned 6,863,464 shares in the company, valued at approximately $166,644,905.92. This represents a 0.26% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 114,900 shares of company stock worth $2,829,906. 32.50% of the stock is currently owned by insiders.

OrthoPediatrics Stock Performance

Shares of NASDAQ KIDS opened at $23.65 on Monday. The stock has a market cap of $617.50 million, a price-to-earnings ratio of -14.08 and a beta of 0.98. The company has a current ratio of 4.78, a quick ratio of 2.17 and a debt-to-equity ratio of 0.28. OrthoPediatrics Corp. has a 1-year low of $14.42 and a 1-year high of $26.74. The stock's 50-day moving average is $21.41 and its 200 day moving average is $18.67.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.04. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%.The business had revenue of $70.51 million during the quarter, compared to analyst estimates of $68.21 million. On average, sell-side analysts anticipate that OrthoPediatrics Corp. will post -1.14 EPS for the current fiscal year.

Wall Street Analyst Weigh In

KIDS has been the topic of a number of recent analyst reports. Truist Financial set a $22.00 target price on shares of OrthoPediatrics in a research note on Wednesday, August 5th. BTIG Research boosted their price target on shares of OrthoPediatrics from $24.00 to $29.00 and gave the stock a "buy" rating in a research note on Thursday, August 20th. Weiss Ratings raised shares of OrthoPediatrics from a "sell (e+)" rating to a "sell (d-)" rating in a report on Wednesday, August 5th. Needham & Company LLC increased their price target on shares of OrthoPediatrics from $30.00 to $35.00 and gave the stock a "buy" rating in a report on Wednesday, August 5th. Finally, TD Cowen restated a "buy" rating on shares of OrthoPediatrics in a research report on Monday, June 15th. Nine investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $26.44.

OrthoPediatrics Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company's product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source